Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Candesartan cilexetil (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Candesartan cilexetil 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Candesartan cilexetil 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Candesartan cilexetil 8 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Candesartan cilexetil 16 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Candesartan cilexetil 32 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Candesartan cilexetil + hydrochlorothiazide 16mg/12.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing candesartan cilexetil and hydrochlorothiazide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Candesartan cilexetil 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Candesartan cilexetil 2 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Candesartan cilexetil 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Candesartan cilexetil 4 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Candesartan cilexetil 8 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Candesartan cilexetil 8 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Candesartan cilexetil 16 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Candesartan cilexetil 16 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Candesartan cilexetil 32 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Candesartan cilexetil 32 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Candesartan cilexetil + hydrochlorothiazide 16mg/12.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Candesartan cilexetil + hydrochlorothiazide 16mg/12.5mg tablet |
Has basis of strength substance (attribute) |
False |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Candesartan cilexetil 4 mg oral tablet |
Has precise active ingredient |
True |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Candesartan cilexetil 8 mg oral tablet |
Has precise active ingredient |
True |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Candesartan cilexetil 16 mg oral tablet |
Has precise active ingredient |
True |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Candesartan cilexetil 32 mg oral tablet |
Has precise active ingredient |
True |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Candesartan cilexetil + hydrochlorothiazide 16mg/12.5mg tablet |
Has precise active ingredient |
False |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Candesartan cilexetil 2 mg oral tablet |
Has precise active ingredient |
True |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has precise active ingredient |
False |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Candesartan cilexetil + hydrochlorothiazide 16mg/12.5mg tablet |
Has basis of strength substance (attribute) |
True |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Candesartan cilexetil + hydrochlorothiazide 16mg/12.5mg tablet |
Has precise active ingredient |
True |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Candesartan cilexetil 32 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has precise active ingredient |
True |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has precise active ingredient |
True |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Candesartan cilexetil 8 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg oral tablet |
Has precise active ingredient |
True |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Candesartan cilexetil 32 mg and hydrochlorothiazide 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Candesartan cilexetil (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |